- $700,000,000 of 2.250% fixed rate senior notes maturing in March 2020 issued by Teva Pharmaceutical Finance IV, LLC; and
- $1,300,000,000 of 2.950% fixed rate senior notes maturing in December 2022 issued by Teva Pharmaceutical Finance Company BV
Analysts are most critical about Teva's plan to cut $5 billion in debt by the end of the year.
For his 'Executive Decision' segment, Cramer again sat down with Joe Papa, chairman and CEO of Valeant
House Democrats start probe into MS drug prices
Jim Cramer is bullish on PayPal, Marriott International, Randgold Resources, and Kirkland Lake.